The cAMP-dependent protein kinase A and protein kinase C-β pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage

Virology

Volumn 245, Issue 2, 1998, Pages 257-269

  Rabbi, Mohammed F ^a   Al Harthi, Lena ^a   Saifuddin, Mohammed ^a   Roebuck, Kenneth A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; PROTEIN KINASE C;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LATENT VIRUS INFECTION; LONG TERMINAL REPEAT; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS REACTIVATION; VIRUS TRANSCRIPTION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; RNA VIRUSES;

EID: 0032486391     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9158     Document Type: Article

References (68)

1. Angel J. B., Saget B. M., Wang M. Z., Wang A., Dinarello C. A., Skolnik P. R. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism. J. Interferon Cytokine Res. 15:1995;575-584.
2. Angel P., Imagawa M., Chiu R., Stein B., Imbra R. J., Rahmsdorf H. J., Jonat C., Herrlich P., Karin M. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell. 49:1987;729-739.
3. Berkhout B., Gatignol A., Rabson A. B., Jeang K. T. TAR-independent activation of the HIV-1 LTR: Evidence that tat requires specific regions of the promoter. Cell. 62:1990;757-767.
4. Bernardo A., Patrizio M., Levi G., Petrucci T. C. Human immunodeficiency virus protein gp120 interferes with beta-adrenergic receptor-mediated protein phosphorylation in cultured rat cortical astrocytes. Cell Mol. Neurobiol. 14:1994;159-173.
5. Biswas D. K., Ahlers C. M., Dezube B. J., Pardee A. B. Pentoxifylline and other protein kinase C inhibitors down-regulate HIV-LTR NF-kappa B induced gene expression. Mol. Med. 1:1994;31-43.
6. Bomsztyk K., Rooney J. W., Iwasaki T., Rachie N. A., Dower S. K., Sibley C. H. Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: Role of protein kinase C. Cell Regul. 2:1991;329-335.
7. Burnette B., Yu G., Felsted R. L. Phosphorylation of HIV-1 gag proteins by protein kinase C. J. Biol. Chem. 268:1993;8698-8703.
8. Canonne-Hergaux F., Aunis D., Schaeffer E. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J. Virol. 69:1995;6634-6642.
9. Chen B. K., Feinberg M. B., Baltimore D. The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth. J. Virol. 71:1997;5495-5504.
10. Chiu R., Boyle W. J., Meek J., Smeal T., Hunter T., Karin M. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell. 54:1988;541-552.
11. Chowdhury I. H., Koyanagi Y., Kobayashi S., Hamamoto Y., Yoshiyama H., Yoshida T., Yamamoto N. The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: Possible involvement of protein kinase C pathway. Virology. 176:1990;126-132.
12. Chowdhury M. I., Koyanagi Y., Horiuchi S., Hazeki O., Ui M., Kitano K., Golde D. W., Takada K., Yamamoto N. cAMP stimulates human immunodeficiency virus (HIV-1) from latently infected cells of monocyte-macrophage lineage: Synergism with TNF-alpha. Virology. 194:1993;345-349.
13. Coates K., Cooke S. J., Mann D. A., Harris M. P. G. Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines. J. Biol. Chem. 272:1997;12289-12294.
14. DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M. A cytokine-responsive I(kappa)B kinase that activates the transcription factor NF-kappaB. Nature. 388:1997;548-554.
15. Dominguez I., Sanz L., Arenzana-Seisdedos F., Diaz-Meco M. T., Virelizier J. L., Moscat J. Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity inXenopus laevis. Mol. Cell Biol. 13:1993;1290-1295.
16. el Kharroubi A., Verdin E. Protein-DNA interactions within DNase I-hypersensitive sites located downstream of the HIV-1 promoter. J. Biol. Chem. 269:1994;19916-19924.
17. Emilie D., Fior R., Jarrousse B., Marfaing-Koka A., Merrien D., Devergne O., Crevon M. C., Maillot M. C., Galanaud P. Cytokines in HIV infection. Int. J. Immunopharmacol. 16:1994;391-396.
18. Finnegan A., Roebuck K. A., Nakai B. E., Gu D. S., Rabbi M. F., Song S., Landay A. L. IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage. J. Immunol. 156:1996;841-851.
19. Folgueira L., McElhinny J. A., Bren G. D., MacMorran W. S., Diaz-Meco M. T., Moscat J., Paya C. V. Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes. J. Virol. 70:1996;223-231.
20. Gebicke-Haerter P. J., Seregi A., Schobert A., Hertting G. The phorbol ester TPA potentiates cholera toxin- and isoproterenol-stimulated cyclic AMP-synthesis in primary astrocyte cultures. Neurochem. Int. 24:1994;1-12.
21. Gibellini D., Zauli G., Re M. C., Furlini G., Lolli S., Borgatti P., Capitani S., La Placa M. CD4 engagement by HIV-1 in TF-1 hematopoietic progenitor cells increases protein kinase C activity and reduces intracellular Ca2+ levels. New Microbiol. 17:1994;85-92.
22. Griffin G. E., Leung K., Folks T. M., Kunkel S., Nabel G. J. Induction of NF-kappa B during monocyte differentiation is associated with activation of HIV-gene expression. Res. Virol. 142:1991;233-238.
23. Gupta S., Aggarwal S., Kim C., Gollapudi S. Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes - a preliminary report. Int. J. Immunopharmacol. 16:1994;197-204.
24. Han X., Becker K., Degen H. J., Jablonowski H., Strohmeyer G. Synergistic stimulatory effects of tumour necrosis factor alpha and interferon gamma on replication of human immunodeficiency virus type 1 and on apoptosis of HIV-1-infected host cells. Eur. J. Clin. Invest. 26:1996;286-292.
25. Haraguchi S., Good R. A., James-Yarish M., Cianciolo G. J., Day N. K. Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopathogenesis in retroviral infections. Proc. Natl. Acad. Sci. USA. 92:1995;5568-5571.
26. Hassan M. I., Nokta M. A., Pollard R. B. Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication. Proc. Soc. Exp. Biol. Med. 204:1993;216-223.
27. Henderson A. J., Connor R. I., Calame K. L. C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines. Immunity. 5:1996;91-101.
28. Hofmann B., Nishanian P., Nguyen T., Insixiengmay P., Fahey J. L. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA. 90:1993a;6676-6680.
29. Hofmann B., Nishanian P., Nguyen T., Liu M., Fahey J. L. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 7:1993b;659-664.
30. Izumi T. [Bovine protein kinase C isotypes transduced into Molt-4/HIV-1 cells augment the expression of HIV-1 genome]. Hokkaido Igaku Zasshi. 70:1995;861-883.
31. Jakobovits A., Rosenthal A., Capon D. J. Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. EMBO J. 9:1990;1165-1170.
32. Kagnoff M. F., Omary M. B., de Grandpre L. Y., Roebuck K. A., Richman D. D., Brenner D. A. Expression of human immunodeficiency virus-1 in human colonic cells. Immunol. Res. 10:1991;452-455.
33. Kim C. H., Gollapudi S., Kim A., Lee T., Gupta S. Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate. AIDS Res. Hum. Retroviruses. 12:1996;1361-1366.
34. Kinter A. L., Poli G., Maury W., Folks T. M., Fauci A. S. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64:1990;4306-4312.
35. Krakauer T. Evidence for protein kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin. Cell. Immunol. 172:1996;224-228.
36. Lahdenpohja N., Henttinen T., Hurme M. Activation of the protein kinase A increases the DNA-binding and transcriptional activity of c-Rel in T cells. Scand. J. Immunol. 43:1996;640-645.
37. Laurence J., Sikder S. K., Jhaveri S., Salmon J. E. Phorbol ester-mediated induction of HIV-1 from a chronically infected promonocyte clone: Blockade by protein kinase inhibitors and relationship to tat-directed trans-activation. Biochem. Biophys. Res. Commun. 166:1990;349-357.
38. Li Y., Mak G., Franza B. R. Jr. In vitro study of functional involvement of Sp1, NF-kappa B/Rel, and AP1 in phorbol 12-myristate 13-acetate-mediated HIV-1 long terminal repeat activation. J. Biol. Chem. 269:1994;30616-30619.
39. Mor-Vaknin N., Torgeman A., Galron D., Lochelt M., Flugel R. M., Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology. 232:1997;337-344.
40. Morimoto B. H., Koshland D. E. Jr. Conditional activation of cAMP signal transduction by protein kinase C: The effect of phorbol esters on adenylyl cyclase in permeabilized and intact cells. J. Biol. Chem. 269:1994;4065-4069.
41. Nokta M., Pollard R. Human immunodeficiency virus infection: Association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology. 181:1991;211-217.
42. Nokta M. A., Pollard R. B. Human immunodeficiency virus replication: modulation by cellular levels of cAMP. AIDS Res. Hum. Retroviruses. 8:1992;1255-1261.
43. Omary M. B., Brenner D. A., de Grandpre L. Y., Roebuck K. A., Richman D. D., Kagnoff M. F. HIV-1 infection and expression in human colonic cells: Infection and expression in CD4+ and CD4- cell lines. AIDS. 5:1991;275-281.
44. Patzold S., Schneider J., Rudolph C., Marme D., Schachtele C. Novel indolocarbazole protein kinase C inhibitors prevent reactivation of HIV-1 in latently infected cells. Antiviral Res. 22:1993;273-283.
45. Pierce J. W., Lenardo M., Baltimore D. Oligonucleotide that binds nuclear factor NF-kappa B acts as a lymphoid-specific and inducible enhancer element. Proc. Natl. Acad. Sci. USA. 85:1988;1482-1486.
46. Poli G., Kinter A. L., Fauci A. S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: Inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:1994;108-112.
47. Poli G., Vicenzi E., Ghezzi S., Lazzarin A. Cytokines in the acquired immunodeficiency syndrome and other infectious diseases. Int. J. Clin. Lab. Res. 25:1995;128-134.
48. Qatsha K. A., Rudolph C., Marme D., Schachtele C., May W. S. Go 6976, a selective inhibitor of protein kinase C, is a potent antagonist of human immunodeficiency virus 1 induction from latent/low-level-producing reservoir cells in vitro. Proc. Natl. Acad. Sci. USA. 90:1993;4674-4678.
49. Rabbi M. F., Al-Harthi L., Roebuck K. A. TNF alpha cooperates with the protein kinase A pathway to synergistically increase HIV-1 long terminal repeat transcription via downstream TRE-like cAMP response elements. Virology. 237:1997;422-429.
50. Rabbi M. F., Saifuddin M., Gu D. S., Kagnoff M. F., Roebuck K. A. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins. Virology. 233:1997;235-245.
51. Raufman J. P. Actions of phorbol esters on levels of cAMP in cholera toxin-treated chief cells from guinea pig stomach. Biochim. Biophys. Acta. 1135:1992;61-66.
52. Read M. A., Whitley M. Z., Gupta S., Pierce J. W., Best J., Davis R. J., Collins T. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 272:1997;2753-2761.
53. Roebuck K. A., Brenner D. A., Kagnoff M. F. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 92:1993;1336-1348.
54. Roebuck K. A., Gu D. S., Kagnoff M. F. Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS. 10:1996;819-826.
55. Roebuck K. A., Rabbi M. F., Kagnoff M. F. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element. AIDS. 11:1997;139-146.
56. Ruegg C. L., Strand M. A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx. Cell. Immunol. 137:1991;1-13.
57. Schreiber E., Matthias P., Muller M. M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
58. Serkkola E., Hurme M. Activation of NF-kappa B by cAMP in human myeloid cells. FEBS Lett. 334:1993;327-330.
59. Stein B., Baldwin A. S. Jr., Ballard D. W., Greene W. C., Angel P., Herrlich P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:1993;3879-3891.
60. Tong-Starkesen S. E., Luciw P. A., Peterlin B. M. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142:1989;702-707.
61. Ushijima H., Ando S., Kunisada T., Schroder H. C., Klocking H. P., Kijjoa A., Muller W. E. HIV-1 gp120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures. J. Acquired Immune Defic. Syndr. 6:1993;339-343.
62. Valerie K., Laster W. S., Cheng L., Kirkham J. C., Reavey P., Kuemmere N. B. Signal transduction and HIV transcriptional activation after exposure to ultraviolet light and other DNA-damaging agents. Photochem. Photobiol. 64:1996;280-285.
63. Van Lint C., Burny A., Verdin E. The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J. Virol. 65:1991;7066-7072.
64. Vicenzi E., Poli G. Regulation of HIV expression by viral genes and cytokines. J. Leukocyte Biol. 56:1994;328-334.
65. Ward N. E., Gravitt K. R., O'Brian C. A. Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein. Cancer Lett. 88:1995;37-40.
66. Weissman D., Poli G., Fauci A. S. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:1995;442-449.
67. Wooten M. W., Seibenhener M. L., Matthews L. H., Zhou G., Coleman E. S. Modulation of zeta-protein kinase C by cyclic AMP in PC12 cells occurs through phosphorylation by protein kinase A. J. Neurochem. 67:1996;1023-1031.
68. Wyss-Coray T., Masliah E., Toggas S. M., Rockenstein E. M., Brooker M. J., Lee H. S., Mucke L. Dysregulation of signal transduction pathways as a potential mechanism of nervous system alterations in HIV-1 gp120 transgenic mice and humans with HIV-1 encephalitis. J. Clin. Invest. 97:1996;789-798.